Print
26 April 2018
GMP News
In a bid to reduce India’s dependence on China for active pharmaceutical ingredients (APIs), the chemicals and fertilizers Indian Ministry of Chemicals and Fertilizers has joined hands with other ministries to draw up a road map for increasing their production in the country.
A high-level task force has been constituted to study global practices and draw up a plan aimed at boosting domestic production of APIs, an 18 April memorandum issued by the chemicals and fertilizers ministry stated. The task force, headed by minister of state Mansukh L. Mandaviya, will include secretaries from the departments of pharmaceuticals and industrial policy and promotion, the ministry of health and family welfare, and the ministries of environment, commerce and biotechnology.
The director general of the Council of Scientific and Industrial Research, and the Drug Controller General of India, along with one member from each of the pharma lobby groups and experts from the private sector, will also be part of the group which is expected to formulate a road map to revive India’s API sector with implementable recommendations.
The RMI group has completed sertain projects
The RMI Group has exited from the capital of portfolio companies:
Marinus Pharmaceuticals, Inc.,
Syndax Pharmaceuticals, Inc.,
Atea Pharmaceuticals, Inc.